Histone Deacetylase Inhibition and Dietary Short-Chain Fatty Acids

Review, Article English OPEN
Licciardi, Paul V.; Ververis, Katherine; Karagiannis, Tom C.;

Changes in diet can also have dramatic effects on the composition of gut microbiota. Commensal bacteria of the gastrointestinal tract are critical regulators of health and disease by protecting against pathogen encounter whilst also maintaining immune tolerance to certa... View more
  • References (84)
    84 references, page 1 of 9

    Marks, P. A., Breslow, R.. Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug. Nature Biotechnology. 2007; 25 (1): 84-90

    Campàs-Moya, C.. Romidepsin for the treatment of cutaneous T-cell lymphoma. Drugs of Today. 2009; 45 (11): 787-795

    Kwa, F. A.A., Balcerczyk, A., Licciardi, P., El-Osta, A., Karagiannis, T. C.. Chromatin modifying agents—the cutting edge of anticancer therapy. Drug Discovery Today. 2011; 16 (13-14): 543-547

    Marks, P. A.. Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions. Biochimica et Biophysica Acta. 2010; 1799 (10-12): 717-725

    Marks, P. A., Xu, W. S.. Histone deacetylase inhibitors: potential in cancer therapy. Journal of Cellular Biochemistry. 2009; 107 (4): 600-608

    Dokmanovic, M., Clarke, C., Marks, P. A.. Histone deacetylase inhibitors: overview and perspectives. Molecular Cancer Research. 2007; 5 (10): 981-989

    Blaheta, R. A., Cinatl, J.. Anti-tumor mechanisms of valproate: a novel role for an old drug. Medicinal Research Reviews. 2002; 22 (5): 492-511

    Rosenberg, G.. The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?. Cellular and Molecular Life Sciences. 2007; 64 (16): 2090-2103

    Johannessen, C. U.. Mechanisms of action of valproate: a commentatory. Neurochemistry International. 2000; 37 (2-3): 103-110

    Gottlicher, M., Minucci, S., Zhu, P., Krämer, O. H., Schimpf, A., Giavara, S., Sleeman, J. P., Lo Coco, F., Nervi, C., Pelicci, P. G., Heinzel, T.. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. The EMBO Journal. 2001; 20 (24): 6969-6978

  • Related Organizations (1)
  • Metrics
Share - Bookmark